INVO Fertility, Inc. (IVF): Nasdaq/NYSE listing notice — NAYA Biosciences Prices $9.5M Public Offering and Receives Nasdaq Notice for Missing Annual Meeting

INVO Fertility, Inc.

NAYA Biosciences closed public offering of 13,615,171 units at $0.70 per unit, raising approximately $9.5 million in gross proceeds.
Company intends to use $2.5M for Wisconsin Fertility Institute, $4M to redeem 4,000 Series C-2 preferred shares, and up to $1.95M for debt repayment.
Nasdaq notified NAYA on Jan 10, 2025 for failing to hold annual meeting within 12 months of fiscal year end; company plans ASM in March 2025.
Offering triggered redemption of $500,000 principal on 7% Senior Secured Convertible Debenture held by FNL and repayment of notes to FirstFire and others.

item 1.01 item 2.04 item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5801(s)(2)(G)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5620(a), 5801(s)(2)(G)

Exact text from the filing

January 10, 2025, the Company received notice (the “Notice”) from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it no longer complies with Nasdaq Listing Rules 5620(a) and 58

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5801(s)(2)(G)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5620(a), 5801(s)(2)(G)

Exact text from the filing

January 10, 2025, the Company received notice (the “Notice”) from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it no longer complies with Nasdaq Listing Rules 5620(a) and 5801(s)(2)(G) that require companies listed on The Nasdaq Capital Market to hold an annual meeting of shareholders (an “ASM”) within twelve months of the fiscal year’s end (the “ASM Rule”). The Company did not hold an ASM in its fiscal year ended December 31, 2024. The Notice has no immediate effect on the listing of the Company’s common stock and the Company’s common stock conti

View on SEC.gov

Browse all listing & compliance notices →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-002543

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.